Cargando…
KMS99220 Exerts Anti-Inflammatory Effects, Activates the Nrf2 Signaling and Interferes with IKK, JNK and p38 MAPK via HO-1
Neuroinflammation is an important contributor to the pathogenesis of neurodegenerative disorders including Parkinson’s disease (PD). We previously reported that our novel synthetic compound KMS99220 has a good pharmacokinetic profile, enters the brain, exerts neuroprotective effect, and inhibits NF-...
Autores principales: | Lee, Ji Ae, Kim, Dong Jin, Hwang, Onyou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Molecular and Cellular Biology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821456/ https://www.ncbi.nlm.nih.gov/pubmed/31656063 http://dx.doi.org/10.14348/molcells.2019.0129 |
Ejemplares similares
-
The Novel Neuroprotective Compound KMS99220 Has an Early Anti-neuroinflammatory Effect via AMPK and HO-1, Independent of Nrf2
por: Lee, Ji Ae, et al.
Publicado: (2018) -
The KMS State of Space-Time at the Planck Scale
por: Bogdanoff, I
Publicado: (2001) -
Derivations and KMS-Symmetric Quantum Markov Semigroups
por: Vernooij, Matthijs, et al.
Publicado: (2023) -
Propofol Induces the Expression of Nrf2 and HO-1 in Echinococcus granulosus via the JNK and p38 Pathway In Vitro
por: Luo, Guangyi, et al.
Publicado: (2023) -
Aprepitant Inhibits JNK and p38/MAPK to Attenuate Inflammation and Suppresses Inflammatory Pain
por: Yang, Yang, et al.
Publicado: (2022)